title: Commentary to the letter of Tjon et al.
authors.forename: Maciej
authors.initials: M
authors.lastname: Siedlar
authors.forename: Loems
authors.initials: L
authors.lastname: Ziegler-Heitbrock
mesh_terms: D017074:Common Variable Immunodeficiency / Q000628:therapy*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology*; D018950:Lipopolysaccharide Receptors / Q000378:metabolism*; D008297:Male; D009000:Monocytes / Q000187:drug effects*; D017452:Receptors, IgG / Q000378:metabolism*
chemical_list: D016756:Immunoglobulins, Intravenous; D018950:Lipopolysaccharide Receptors; D017452:Receptors, IgG